9.25
price down icon1.07%   -0.10
after-market Handel nachbörslich: 9.30 0.05 +0.54%
loading

Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten

pulisher
Apr 03, 2025

Greenwich LifeSciences reports progress on FLAMINGO-01 trial By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

GLSI stock touches 52-week low at $9.05 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial - Curetoday

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich Lifesciences Provides Global Update On Flamingo-01 - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences Provides Global Update on FLAMINGO-01 - GlobeNewswire

Apr 03, 2025
pulisher
Apr 03, 2025

Greenwich LifeSciences reports progress on FLAMINGO-01 trial - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Major Breakthrough: Cancer Prevention Trial Reports Positive Data, Elite Hospitals Join - Stock Titan

Apr 03, 2025
pulisher
Apr 02, 2025

Flamingo cancer vaccine in phase III pink, Greenwich time nigh? - BioWorld MedTech

Apr 02, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences stock rises on cancer shot data (GLSI) - Seeking Alpha

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich Lifesciences Announces Positive Immune Response Data From FLAMINGO-01 Phase III Clinical Trial - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Trading Down 6.7%Time to Sell? - MarketBeat

Apr 02, 2025
pulisher
Apr 01, 2025

Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently - simplywall.st

Apr 01, 2025
pulisher
Mar 31, 2025

Greenwich LifeSciences Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

How To Trade (GLSI) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-Up Period for Directors, Officers to March 2026 - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026 - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx, Alteogen - Barchart

Mar 26, 2025
pulisher
Mar 26, 2025

HER2-Positive Breast Cancer Pipeline 2025: Therapies, MOA - openPR.com

Mar 26, 2025
pulisher
Mar 25, 2025

GLSI stock touches 52-week low at $10.52 amid market challenges - Investing.com

Mar 25, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences gets DSMB approval to continue late-stage trial of GLSI-100 - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Says Preliminary Safety Data for Breast Cancer Therapy Appears Consistent With Prior Trials - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences reports positive safety data on GLSI-100 - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction - StockTitan

Mar 17, 2025
pulisher
Mar 10, 2025

Trading (GLSI) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 05, 2025

Non-Small Cell Lung Cancer Clinical Trial Pipeline | 100+ Companies Pioneering the Future of Treatment - openPR

Mar 05, 2025
pulisher
Mar 05, 2025

55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

Learn to Evaluate (GLSI) using the Charts - news.stocktradersdaily.com

Feb 27, 2025
pulisher
Feb 22, 2025

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Sees Large Increase in Short Interest - MarketBeat

Feb 22, 2025
pulisher
Feb 21, 2025

Short Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Increases By 5.1% - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Verra Mobility Corporation (NASDAQ: VRRM) - PR Newswire

Feb 20, 2025
pulisher
Feb 18, 2025

Pre-market Movers: TNXP, INBS, SMMT, NDRA... - RTTNews

Feb 18, 2025
pulisher
Feb 18, 2025

Research Analysts Set Expectations for GLSI FY2024 Earnings - MarketBeat

Feb 18, 2025
pulisher
Feb 15, 2025

HC Wainwright Reiterates Buy Rating for Greenwich LifeSciences (NASDAQ:GLSI) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

What is HC Wainwright’s Estimate for GLSI FY2024 Earnings? - Defense World

Feb 15, 2025
pulisher
Feb 12, 2025

Greenwich LifeSciences reports progress in FLAMINGO-01 trial - MSN

Feb 12, 2025
pulisher
Feb 11, 2025

Greenwich LifeSciences (NASDAQ:GLSI) Given “Buy” Rating at HC Wainwright - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Greenwich LifeSciences, Inc. (NASDAQ: GLSI) - PR Newswire

Feb 11, 2025
pulisher
Feb 10, 2025

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

Greenwich LifeSciences reports progress in FLAMINGO-01 trial By Investing.com - Investing.com UK

Feb 10, 2025
pulisher
Feb 10, 2025

Clinical Trial Success: Greenwich's Breast Cancer Immunotherapy Achieves Critical Patient Milestone - StockTitan

Feb 10, 2025
pulisher
Feb 06, 2025

Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI) - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

(GLSI) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 06, 2025
pulisher
Jan 30, 2025

EMA approves addition of sites to Greenwich LifeSciences’ breast cancer trial - Yahoo Finance

Jan 30, 2025
pulisher
Jan 29, 2025

Greenwich LifeSciences Gets EU Drug Regulator Approval to Add Sites to GLSI-100 Late-Stage Trial - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

Greenwich LifeSciences stock gains on approval to add additional sites to Flamingo-01 in Europe - MSN

Jan 29, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):